Julie Yoo will make investments out of the firm's bio fund.
One of the major problems that technology companies working to find a cure for cancer need to solve is finding a safe, minimally invasive way to detect cancers early. Almost all cancer screening will
Innovation Endeavors, the fund backed by Google’s Eric Schmidt, has for years now been taking a novel approach to working on difficult and still-evolving problems, like cybersecurity and food sh
Almost exactly two years ago, the venture firm Andreessen Horowitz took the wraps off a $200 million “biofund” that aimed to invest at the intersection of biology and engineering and was b
Though the region known as Silicon Valley covers dozens of municipalities, a few cities get outsized attention in tech circles. Everyone knows Palo Alto, Mountain View, San Jose and San Francisco as h
The application of AI/ML in healthcare is reshaping the industry and making what was once impossible into a tangible reality.
Freenome, a two-year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing of cancer, has raised a huge Series A round — $65 million — led by Andreessen Horowitz,
Freenome, a year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing of cancer, has landed $5.5 million in seed funding led by Andreessen Horowitz, with participation from F